INTINI, Francesco Paolo
 Distribuzione geografica
Continente #
NA - Nord America 6.187
EU - Europa 2.343
AS - Asia 2.064
SA - Sud America 535
Continente sconosciuto - Info sul continente non disponibili 169
AF - Africa 82
OC - Oceania 2
Totale 11.382
Nazione #
US - Stati Uniti d'America 6.031
RU - Federazione Russa 824
SG - Singapore 811
CN - Cina 603
IT - Italia 511
BR - Brasile 422
SE - Svezia 335
HK - Hong Kong 249
UA - Ucraina 153
DE - Germania 133
FI - Finlandia 127
VN - Vietnam 99
FR - Francia 98
IN - India 79
CA - Canada 69
GB - Regno Unito 64
BD - Bangladesh 40
AR - Argentina 28
CO - Colombia 24
IQ - Iraq 23
TR - Turchia 21
ZA - Sudafrica 20
CI - Costa d'Avorio 18
MX - Messico 17
BE - Belgio 16
SA - Arabia Saudita 16
ID - Indonesia 15
PK - Pakistan 15
VE - Venezuela 15
EC - Ecuador 14
IE - Irlanda 14
PL - Polonia 13
ES - Italia 12
MA - Marocco 11
CL - Cile 10
IR - Iran 10
KE - Kenya 10
NI - Nicaragua 10
PH - Filippine 10
CZ - Repubblica Ceca 9
JP - Giappone 9
PY - Paraguay 9
CR - Costa Rica 8
GP - Guadalupe 8
IL - Israele 8
MY - Malesia 8
UZ - Uzbekistan 8
GT - Guatemala 7
HN - Honduras 7
JO - Giordania 7
PR - Porto Rico 7
SV - El Salvador 7
AT - Austria 6
CW - ???statistics.table.value.countryCode.CW??? 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
EE - Estonia 5
KZ - Kazakistan 5
NL - Olanda 5
SC - Seychelles 5
UY - Uruguay 5
AZ - Azerbaigian 4
BO - Bolivia 4
ET - Etiopia 4
PE - Perù 4
DZ - Algeria 3
JM - Giamaica 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AL - Albania 2
BH - Bahrain 2
EG - Egitto 2
HR - Croazia 2
KG - Kirghizistan 2
LT - Lituania 2
NP - Nepal 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
DM - Dominica 1
GE - Georgia 1
GR - Grecia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
Totale 11.215
Città #
Fairfield 696
Ashburn 530
Woodbridge 462
Chandler 440
Singapore 405
San Jose 384
Jacksonville 316
Houston 292
Seattle 284
Nyköping 276
Hong Kong 246
Cambridge 236
Wilmington 211
Milan 198
Ann Arbor 156
Beijing 132
Nanjing 128
Council Bluffs 116
New York 115
Lawrence 92
Roxbury 92
Boardman 89
Lauterbourg 80
Princeton 70
Los Angeles 64
Des Moines 63
Bari 62
Rome 57
Nanchang 51
Helsinki 47
Washington 46
São Paulo 43
Ho Chi Minh City 42
Brooklyn 41
Inglewood 39
Santa Clara 37
Dallas 31
San Diego 30
Jiaxing 26
Buffalo 25
Dearborn 25
Shenyang 24
Hanoi 22
Pune 20
Abidjan 18
Hebei 18
Rio de Janeiro 18
Figino 17
Munich 17
San Mateo 17
Brussels 16
Changsha 16
Tianjin 16
Kunming 14
Naples 14
Chicago 13
Johannesburg 13
Medellín 13
Atlanta 12
Columbus 12
Jinan 12
Leawood 12
Molfetta 12
Baghdad 11
Dublin 11
Guangzhou 11
Montreal 11
Frankfurt am Main 10
Managua 10
Nairobi 10
San Francisco 10
Warsaw 10
Ardabil 9
Curitiba 9
Jakarta 9
Noicattaro 9
Phoenix 9
Riyadh 9
Toronto 9
Belo Horizonte 8
Bologna 8
Brno 8
Corridonia 8
Denver 8
London 8
Monmouth Junction 8
Mumbai 8
Tokyo 8
Brasília 7
Fortaleza 7
Shanghai 7
Stockholm 7
Tashkent 7
Turin 7
Vancouver 7
Amman 6
Augusta 6
Birmingham 6
Bogotá 6
Chennai 6
Totale 7.429
Nome #
The First Example of a Dinuclear Platinum(III) Complex with Three Bridging Ligands 800
Anticancer potential of a photoactivated transplatin derivative containing the methylazaindole ligand mediated by ROS generation and DNA cleavage 244
Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects 226
Novel Antitumor Cisplatin and Transplatin Derivatives Containing 1‑Methyl-7-Azaindole: Synthesis, Characterization, and Cellular Responses 207
Addition of Hydroxide, Alkoxide, and Carboxylate Anions to Platinum-bonded Ethylene 169
Isomerism of amides coordinated to platinum. X-ray crystal structure of dichloro-bisacetamide-platinum(II) 166
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 163
Lantern-Shaped” Platinum(III) Complexes with Axially Bound 9-Ethylguanine or 1-Methylcytosine (L) of General Formula [Pt2{HN=C(But)O}4L2](NO3)2 156
Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)] 152
One-Pot Synthesis of New Organometallic Compounds with Platinum-Carbon Bond 149
Atropisomerization of cis-Bis(5'GMP)-Platinum(II)-Diamine complexes with Non-C2-symmetrical asymmetric diamine ligands containing NH groups directed to one side of the coordination plane 147
Cytotoxic trans-oriented iminoether platinum complexes – Kinetics of binding to DNA oligonucleotides determined by 15N NMR spectroscopy 143
Conformer distribution in (cis-1,4-DACH)bis(guanosine5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin 143
NMR and X-ray Structural Characterization of a Cisplatin Analogue Able To Slow Down the Pt−N7 Rotation of a Coordinated Guanine Base by a Billion-Fold Times: 2,2'-Bipiperidine(dimethylmalonato)platinum(II) Complex 142
A novel head-to-head conformer of d(GpG) cross-linked by Pt: New light on the conformation of such cross-links formed by Pt anticancer drugs 141
Cytotoxic trans-oriented platinum complexes only form adducts with single-stranded oligodeoxynucleotides 139
Potentiation of cytotoxic action of cis-[PtCl2(NH3)(1M7AI)] by UVA irradiation. Mechanistic insights 137
Single-Stranded Oligonucleotide Adducts Formed by Pt Complexes Favoring Left-Handed Base Canting: Steric Effect of Flanking Residues and Relevance to DNA Adducts Formed by Pt Anticancer Drugs 136
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 135
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine 135
NMR and X-ray characterization of a platinum(II) complex with (−)sparteine 134
Bis[iodo(N,N,N′,N'',N''-pentamethyldiethyl-enetriamine- kappa N-3)platinum(II)] di-μ-iodobis[diiodoplatinate(II)] 133
Influence of carrier ligand NH hydrogen bonding to the O6 and phosphate group of Guanine nucleotides in Platinum complexes with a single guanine ligand 133
Insights into the Molecular Mechanisms of Protein Platination from a Case Study: The Reaction of Anticancer Platinum(II) Iminoethers with Horse Heart Cytochrome c 132
Dependence of the Reduction Products of Platinum(IV) Prodrugs upon the Configuration of the Substrate, Bulk of the Carrier Ligands, and Nature of the Reducing Agent 127
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 124
Chirality-Controlling Chelate (CCC) Ligands in Analogs of Platinum Anticancer Agents. Influence of N9 Substituents of Guanine Derivatives (G) on the Distribution of Chiral Conformers of (CCC)PtG2 with CCC = N,N'-Dimethyl-2,3-diaminobutane 124
Platinum amides from platinum nitriles: X-ray crystal structure of trans-dichloro-bis(1-imino-1-hydroxy-2,2-dimethylpropane)platinum(II) 122
Synthesis and structural characterization of isomeric "lantern-shaped" platinum(III) complexes of formula [Pt2(PPh3)X{N(H)C(R)O}4](NO3)2 (X=PPh3, H2O) 119
Unusual reactivity at a platinum center determined by the ligands and the solvent environment 117
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 116
trans-Chloridobis[(Z)-1-imino-1-methoxyethane-N](triphenylphosphane-P)platinum(II) chloride monohydrate 115
Solution Behavior of Amidine Complexes: An Unexpected cis/trans Isomerization and Formation of Di- and Trinuclear Platinum(III) and Platinum(II) Species 114
Cisplatin and zoledronic acid: two drugs combined in a Pt(II) complex with potential antitumor activity towards bone tumors and metastases 113
Synthesis and X-ray crystal structure of a trans-dichloro(1-cyano-2,2-dimethylpropane)(1-imino-1-hydroxy-2,2-dimethylpropane)platinum(II) 113
Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration 111
Isolation, Characterization, and Kinetics of Formation of the cis and trans Isomers of Bis(acetonitrile)dichloroplatinum(II) 111
Effects of six-membered-ring conformation on the rotamer distribution and rate of atropisomerization in platinum(II)-guanine compounds: 2,4-bis(methylamino)pentane complexes 110
Energetics, conformation, and recognition of DNA duplexes modified by methylated analogues of [PtCl(dien)]+ 109
Solvolysis of Platinum Complexes with Substituted Ethylenediamines in Dimethylsulfoxide 109
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 109
Cyclodextrin polymers as carriers for the platinum-based anticancer agent LA-12 109
New steric hindrance approach employing the hybrid ligand 2-aminomethylpiperidine for diminishing dynamic motion problems of platinum anticancer drug adducts containing guanine derivatives 108
Factors Influencing the Configuration and Conformation of Diamine Chelate Rings in Platinum(II) Compounds: 2,4- Bis(methylamino)pentane Complexes 105
Synthesis, characterization, and biological activity of platinum II, III, and IV pivaloamidine complexes 105
null 104
A trans-platinum complex showing higher antitumor activity than the cis congeners 103
Structural characterization of the “lantern-shaped” platinum(III) complex [Pt2Cl2{N(H)C(But)O}4] 101
Synthesis and spectroscopic and structural characterization of different configurations of the tridentate amine ligand N,N’,N’’-trimethyldiethylenetriamine coordinated to platinum 101
Retro-Models of Pt Anticancer Drug DNA Adducts: Chirality-Controlling Chelate (CCC) Ligand Restriction of Guanine Dynamic Motion in (2,2'-Bipiperidine)PtG2 Complexes (G = Guanine Derivative) 100
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 100
Sinthesis and stereochemical characterisation of platinum(II) complexes with the antiviral agents penciclovir and famciclovir 98
IRREVERSIBLE ADDITION OF CARBON NUCLEOPHILES TO ETHYLENE IN CATIONIC PLATINUM(II) COMPLEXES 96
Complessi antitumorali di platino a geometria trans 96
Platinum(II) complexes with the purine derivatives Penciclovir and Famciclovir; monoadducts with potential antitumor and antiviral activity 95
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 95
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 93
Synthesis and X-Ray Structural Characterization of the First Unbridged Diplatinum(III) Compound: Bis[bis(1-imino-1-hydroxy-2,2-dimethyl-propane)-trichloroplatinum(III)] 93
Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's 93
Synthesis and Crystal Structure of a Trans-Diaquabis(amidato) Complex of Platinum(II) 92
Stereochemical Investigations of Cationic Olefin Complexes of Platinum(II) Containing Chiral Diamines: a Sequence of Four Asymmetric Centres (N, C, C and N) in the chelate ring 91
null 89
NUCLEOPHILIC-ATTACK OF METHANOL ON BIS(BENZONITRILE)DICHLOROPLATINUM - FORMATION OF MONO-IMIDO AND BIS-IMIDO ESTER DERIVATIVES 89
null 88
X-ray Structural Characterization of the Bis-Guanine Derivative of a Cisplatin Analogue Having Just One Proton on Each Coordinated Nitrogen and a Head-to-Head Conformation: [Pt{(±)-N,N'-dimethylbutane-2,3-diamine}(9-ethyl-guanine)2]dinitrate 87
Biochemical aspects of antitumor effects of a new platinum(IV) drug 87
Sinthesis and characterisation of the amidine complexes trans-[PtCl(NH3)(HN=C(NH2)R)2]Cl (R= Me,Ph,CH2Ph) derived from addition of NH3 to the coordinated nitriles in trans-[PtCl2(NCR)2] 84
Retro-modeling in Pt anticancer drug chemistry 83
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 83
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 82
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 81
Platinum Amides from Platinum Nitriles: X-ray Crystal Structures of the Unbridged Dinuclear Compounds Bis[bis(1-imino-1-hydroxy-2,2-dimethylpropane)dichloro-platinum(II)] and Bis[bis(1-imino-1-hydroxy-2,2-dimethylpropane)(1-amino-1-oxo-2,2-dimethylpropane)dichloro-platinum(II)] 81
Isomerism of amides coordinated to platinum - X-ray crystal structure of O-bonded acetamide in a platinum(II) complex 80
A new generation of platinum anticancer complexes with trans geometry 80
null 80
Isomerization of Platinum-Coordinated Iminoethers Induced by Spectator Ligands: Stabilization of the Z anti Configuration 78
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands 78
X-ray Structure of the first Platinum Complexes with Z Configuration of the Iminoether Ligands: trans Dichlorobis(1-imino-1-methoxy- 2,2'-dimethylpropane)platinum(II) and trans-Tetrachlorobis(1-imino-1-methoxy-2,2'-dimethylpropane)platinum(IV) 76
Two polymorphs of potassium trichloro[diethyl (methylsulfinylmethyl)phosphonate-kS]platinum(II) with Z' = 1 and 3 in the space group P212121 75
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties 75
Four- versus Five-coordination in Palladium(II) and Platinum(II) Complexes Containing 2,9-Dimethyl-1,10-phenanthroline (dmphen). Crystal Structures of [PtCl2(dmphen)] and [Pt(h2-C2H4)Cl2(dmphen)] 73
Synthesis and Crystal Structure of the First Trinuclear Chloride-bridged Platinum(II) Complex with Mutually Perpendicular Co-ordination Planes: cyclo-Tri-mu-chloro-tris[chloro(1-hydroxy-1-imino-2,2-dimethylpropane)platinum(II)]-Dichloromethane (0.5/1) 73
MECHANISTIC AND STEREOCHEMICAL INVESTIGATION OF IMINO ETHERS FORMED BY ALCOHOLYSIS OF COORDINATED NITRILES - X-RAY CRYSTAL-STRUCTURES OF CIS-BIS(1-IMINO-1-METHOXYETHANE)DICHLOROPLATINUM(II) AND TRANS-BIS(1-IMINO-1-METHOXYETHANE)DICHLOROPLATINUM(II) 70
Synthesis and X-Ray Characterization of Two Unbridged Diplatinum(III) Compounds: cis and trans-Bis[bis(1-imino-1-methoxyethane)trichloroplatinum(III)]. Transient Species in the Oxidation of Platinum(II) to Platinum(IV) 70
Dna interaction properties of new platinum-iminoether derivatives with different configuration at the iminoether ligands 67
null 67
null 66
Synthesis and in vitro and in vivo antitumour activity of new platinum-iminoether derivatives with different configuration at the iminoether ligands 65
Nucleophilic Attack of Amine and Hydroxide to Platinum Dibenzonitrile Dichloride. Crystal structure of [Pt(NH=CPhN-t-BuCH2CH2NH-t-Bu)Cl(NHCOPh)] (2) and cis-[Pt(NH=CPhN-t-BuCH2CH2NH-t-Bu)Cl2(NCPh)](3) 65
SYNTHESIS, MUTAGENICITY, BINDING TO PBR-322 DNA AND ANTITUMOR-ACTIVITY OF PLATINUM(II) COMPLEXES WITH ETHAMBUTOL 63
Stereochemically Controlled Ligands Influence Atropisomerization of Pt(II) Nucleotide Complexes. Evidence for Head-to-Head and Stable a Head-to-Tail Atropisomers 63
Replacement of a NH3 by an iminoether in transplatin makes an antitumor drug from an inactive compound 62
Synthesis and characterization of new platinum(II) complexes with cyclic iminoether-type ligands having the azomethine group out of cycle 61
Kinetic study of the reaction between an antitumor 15N labeled trans- platinum iminoether complex and GMP by [1H,15N] HMQC NMR 60
New platinum antitumor complexes with chiral diamines 59
Viewing early stages of guanine nucleotide attach on Pt(II) complexes designed with in-plane bulk to trap initial adducts. Relevance to cis-Type Pt(II) anticancer drugs 59
null 58
In vitro antitumour activity and cellular pharmacological properties of the platinum-iminoether complex trans-[PtCl2{E-HN=C(OMe)Me}2] 57
null 55
New concepts relevant to cisplatin anticancer activity from unique spectral features providing evidence that adjacent guanines in d(GpG), intrastrand-cross-linked at N7 by a cis-platinum(II) moiety, can adopt a head-to-tail arrangement 54
Totale 11.126
Categoria #
all - tutte 45.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022531 0 0 0 0 34 39 28 42 58 61 135 134
2022/20231.209 197 101 79 112 170 166 6 148 179 14 19 18
2023/2024399 31 63 10 33 38 144 2 14 7 4 1 52
2024/20251.296 48 31 125 32 20 78 115 87 59 66 182 453
2025/20263.296 364 140 139 282 279 143 307 66 940 217 68 351
2026/2027822 61 163 132 411 55 0 0 0 0 0 0 0
Totale 11.382